Variant report
Variant | nsv821835 |
---|---|
Chromosome Location | chr2:181695124-181704766 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-UBE2E3-4 | chr2:181696809-181696952 | ucscGeneNc_uc002uns_1 |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7590308 | chr2:181696810-181696811 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs10183078 | chr2:181696815-181696816 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs535446360 | chr2:181696841-181696842 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs549058445 | chr2:181696854-181696855 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs10183096 | chr2:181696869-181696870 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs183846360 | chr2:181696905-181696906 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs557645531 | chr2:181696909-181696910 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs11892044 | chr2:181696926-181696927 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs536765424 | chr2:181696936-181696937 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs374239827 | chr2:181696941-181696942 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs374692583 | chr2:181704041-181704042 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs367834746 | chr2:181704053-181704054 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371675738 | chr2:181704090-181704091 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs572515528 | chr2:181704100-181704101 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs6761806 | chr2:181704111-181704112 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs6433862 | chr2:181704132-181704133 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6761817 | chr2:181704152-181704153 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571639299 | chr2:181704170-181704171 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537445553 | chr2:181704186-181704187 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs551054138 | chr2:181704211-181704212 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567750498 | chr2:181704212-181704213 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs536389670 | chr2:181704223-181704224 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs58223344 | chr2:181704230-181704231 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573390016 | chr2:181704245-181704246 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs539293773 | chr2:181704250-181704251 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs369868277 | chr2:181704256-181704257 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558829210 | chr2:181704315-181704316 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189749287 | chr2:181704352-181704353 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs543799319 | chr2:181704357-181704358 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181306157 | chr2:181704385-181704386 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74628700 | chr2:181704397-181704398 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189912677 | chr2:181704449-181704450 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs560261350 | chr2:181704485-181704486 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532228216 | chr2:181704513-181704514 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs546072348 | chr2:181704529-181704530 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562780471 | chr2:181704552-181704553 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs563675992 | chr2:181704565-181704566 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs77517901 | chr2:181704570-181704571 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550988671 | chr2:181704599-181704600 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs545935506 | chr2:181704616-181704617 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs114650902 | chr2:181704621-181704622 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528243477 | chr2:181704638-181704639 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs71425685 | chr2:181704665-181704666 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs10168493 | chr2:181704684-181704685 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs149900025 | chr2:181704727-181704728 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs567009241 | chr2:181704737-181704738 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs111419912 | chr2:181704754-181704755 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182239927 | chr2:181704756-181704757 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs558768960 | chr2:181704760-181704761 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:181704000-181704600 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
2 | chr2:181704000-181704800 | Active TSS | HUES6 Cell Line | embryonic stem cell |
3 | chr2:181704200-181704600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr2:181704400-181704800 | Active TSS | K562 | blood |